| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0166-3542(03)00109-8 |
| P8608 | Fatcat ID | release_kjjlb4baebau3dbf6nnz7whzpq |
| P698 | PubMed publication ID | 12927305 |
| P50 | author | John D Morrey | Q66760143 |
| P2093 | author name string | Justin G Julander | |
| Richard J Colonno | |||
| Robert W Sidwell | |||
| P2860 | cites work | Potent efficacy of entecavir (BMS-200475) in a duck model of hepatitis B virus replication | Q28366818 |
| Metabolic studies on BMS-200475, a new antiviral compound active against hepatitis B virus | Q28369473 | ||
| Identification of BMS-200475 as a potent and selective inhibitor of hepatitis B virus | Q28379014 | ||
| Nuclear covalently closed circular viral genomic DNA in the liver of hepatocyte nuclear factor 1 alpha-null hepatitis B virus transgenic mice | Q33865967 | ||
| High-level hepatitis B virus replication in transgenic mice | Q35847850 | ||
| In vitro inhibition of hepadnavirus polymerases by the triphosphates of BMS-200475 and lobucavir. | Q39559675 | ||
| Efficacy of the carbocyclic 2'-deoxyguanosine nucleoside BMS-200475 in the woodchuck model of hepatitis B virus infection | Q39559680 | ||
| Efficacies of entecavir against lamivudine-resistant hepatitis B virus replication and recombinant polymerases in vitro | Q39652624 | ||
| Safety and efficacy of oral entecavir given for 28 days in patients with chronic hepatitis B virus infection. | Q43722501 | ||
| Long-term entecavir treatment results in sustained antiviral efficacy and prolonged life span in the woodchuck model of chronic hepatitis infection. | Q43779173 | ||
| Characterizing antiviral activity of adefovir dipivoxil in transgenic mice expressing hepatitis B virus | Q44036705 | ||
| Evaluation of anti-hepatitis B virus (HBV) drugs using the HBV transgenic mouse: application of the semiquantitative polymerase chain reaction (PCR) for serum HBV DNA to monitor the drug efficacy | Q45758941 | ||
| P433 | issue | 3 | |
| P921 | main subject | Hepatitis B virus | Q6844 |
| entecavir | Q418586 | ||
| P304 | page(s) | 155-161 | |
| P577 | publication date | 2003-08-01 | |
| P1433 | published in | Antiviral Research | Q4775352 |
| P1476 | title | Characterization of antiviral activity of entecavir in transgenic mice expressing hepatitis B virus | |
| P478 | volume | 59 |
| Q46263692 | Activity of nucleic acid polymers in rodent models of HBV infection |
| Q34138917 | Anti-hepatitis B virus activity of ORI-9020, a novel phosphorothioate dinucleotide, in a transgenic mouse model |
| Q35052956 | Breaking B and T cell tolerance using cationic lipid--DNA complexes (CLDC) as a vaccine adjuvant with hepatitis B virus (HBV) surface antigen in transgenic mice expressing HBV |
| Q59352117 | Cell and Animal Models for Studying Hepatitis B Virus Infection and Drug Development |
| Q34692139 | Construction of a single lentiviral vector containing tetracycline-inducible Alb-uPA for transduction of uPA expression in murine hepatocytes |
| Q40073982 | Development of a novel mouse model to evaluate drug candidates against hepatitis B virus |
| Q33784869 | Effect of dipterinyl calcium pentahydrate on hepatitis B virus replication in transgenic mice |
| Q27486380 | Efficacy of cationic lipid–DNA complexes (CLDC) on hepatitis B virus in transgenic mice |
| Q35964745 | Entecavir for the treatment of chronic hepatitis B. |
| Q34584406 | Entecavir: a new nucleoside analog for the treatment of chronic hepatitis B infection |
| Q38035173 | Experimental models and therapeutic approaches for HBV. |
| Q38364526 | Gender disparity in chronic hepatitis B: Mechanisms of sex hormones |
| Q64966438 | In Vivo Model Systems for Hepatitis B Virus Research. |
| Q37677390 | Liver immune-pathogenesis and therapy of human liver tropic virus infection in humanized mouse models. |
| Q38534533 | Modeling hepatitis B virus infection, immunopathology and therapy in mice |
| Q57494795 | Mouse models for hepatitis B virus research |
| Q27002598 | Mouse models of hepatitis B virus infection comprising host-virus immunologic interactions |
| Q59349492 | Sexual dimorphism in hepatitis B and C and hepatocellular carcinoma |
| Q27007019 | The Discovery and Development of a Potent Antiviral Drug, Entecavir, for the Treatment of Chronic Hepatitis B |
Search more.